Spiriva and Flavin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Spiriva (tiotropium bromide monohydrate) and Flavin (riboflavin (vitamin b2)). Common drug interactions include dyspnoea among females and deafness among males.

The phase IV clinical study analyzes what interactions people have when they take Spiriva and Flavin. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Spiriva?

Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 156,666 Spiriva users. Check the latest studies of Spiriva.

What is Flavin?

Flavin has active ingredients of riboflavin (vitamin b2). eHealthMe is studying from 2,870 Flavin users. Check the latest studies of Flavin.

On Jul, 11, 2026

27 people who take Spiriva and Flavin together, and have interactions are studied.

What are the common drug interactions of Spiriva and Flavin, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Hypersensitivity
Impaired gastric emptying
Pain
Vomiting
Forced expiratory volume decreased (decreased lung expired air volume)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
General physical health deterioration (weak health status)
Hyperchlorhydria (gastric acid levels are higher in stomach)
Malaise (a feeling of general discomfort or uneasiness)

male:

Deafness
Drug ineffective
Injection site erythema (redness at injection site)
Injection site pain
Injection site swelling
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Renal failure (kidney dysfunction)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Urticaria (rash of round, red welts on the skin that itch intensely)

What are the common drug interactions of Spiriva and Flavin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Drug ineffective
Injection site pain

40-49:

Dyspnoea (difficult or laboured respiration)
Forced expiratory volume decreased (decreased lung expired air volume)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
General physical health deterioration (weak health status)
Hyperchlorhydria (gastric acid levels are higher in stomach)
Impaired gastric emptying
Malaise (a feeling of general discomfort or uneasiness)
Obstructive airways disorder (a progressive disease that makes it hard to breathe)
Osteonecrosis (death of bone)
Pain

50-59:

n/a

60+:

Deafness
Drug ineffective
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Confusional state
Cough
Disease complication
Disease progression
Dysarthria (speech disorder)
Dyspnoea (difficult or laboured respiration)
Epistaxis (bleed from the nose)

What are the existing conditions these people have? *

Asthma: 6 people, 22.22%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 11.11%
Migraine (headache): 3 people, 11.11%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 7.41%
Immunodeficiency Common Variable: 2 people, 7.41%
Immune System Disorder: 2 people, 7.41%
Cystic Fibrosis (disease of the secretary glands): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Spiriva and Flavin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously